Agilent Technologies Inc (A)vsMedpace Holdings Inc (MEDP)
A
Agilent Technologies Inc
$146.93
+2.66%
HEALTHCARE · Cap: $41.41B
MEDP
Medpace Holdings Inc
$587.52
+0.75%
HEALTHCARE · Cap: $16.49B
Smart Verdict
WallStSmart Research — data-driven comparison
Agilent Technologies Inc generates 165% more annual revenue ($7.37B vs $2.78B). A leads profitability with a 19.5% profit margin vs 17.7%. A appears more attractively valued with a PEG of 1.25. MEDP earns a higher WallStSmart Score of 68/100 (B-).
A
Buy63
out of 100
Grade: C+
MEDP
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-66.4%
Fair Value
$77.48
Current Price
$146.93
$69.45 premium
Margin of Safety
-39.2%
Fair Value
$304.57
Current Price
$587.52
$282.95 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 25.6%
Every $100 of equity generates 113 in profit
Conservative balance sheet, low leverage
Strong operational efficiency at 20.8%
17.2% revenue growth
Earnings expanding 37.1% YoY
Areas to Watch
Moderate valuation
Grey zone — moderate risk
Weak financial health signals
Premium valuation, high expectations priced in
Grey zone — moderate risk
Expensive relative to growth rate
Trading at 37.8x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : A
The strongest argument for A centers on Operating Margin. Profitability is solid with margins at 19.5% and operating margin at 25.6%. PEG of 1.25 suggests the stock is reasonably priced for its growth.
Bull Case : MEDP
The strongest argument for MEDP centers on Return on Equity, Debt/Equity, Operating Margin. Profitability is solid with margins at 17.7% and operating margin at 20.8%. Revenue growth of 17.2% demonstrates continued momentum.
Bear Case : A
The primary concerns for A are P/E Ratio, Altman Z-Score, Piotroski F-Score.
Bear Case : MEDP
The primary concerns for MEDP are P/E Ratio, Altman Z-Score, PEG Ratio.
Key Dynamics to Monitor
A profiles as a mature stock while MEDP is a growth play — different risk/reward profiles.
A carries more volatility with a beta of 1.24 — expect wider price swings.
MEDP is growing revenue faster at 17.2% — sustainability is the question.
A generates stronger free cash flow (439M), providing more financial flexibility.
Bottom Line
MEDP scores higher overall (68/100 vs 63/100), backed by strong 17.7% margins and 17.2% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Agilent Technologies Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Agilent Technologies, Inc. is an American analytical instrumentation development and manufacturing company that offers its products and services to markets worldwide. Its global headquarters is located in Santa Clara, California.
Medpace Holdings Inc
HEALTHCARE · DIAGNOSTICS & RESEARCH · USA
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in Cincinnati, Ohio.
Compare with Other DIAGNOSTICS & RESEARCH Stocks
Want to dig deeper into these stocks?